GERN 傑龍

添加自選

1.710
+0.010+0.59%

交易中 03/20 11:46 (美東)

10.89億總市值-6.33市盈率TTM

關於傑龍公司

傑龍公司是一家臨牀階段生物製藥公司，專注於研究和開發癌症治療藥物。公司的在研藥物 Imelstat 正在接受測試，用於治療骨髓增生異常綜合徵，一種血液疾病，和骨髓纖維化，一種影響骨髓的罕見血癌。公司通過合作協議，里程碑，版稅和許可安排獲得收入。傑龍擁有該藥物的各種權利。該公司的業務只有一個分部，即開發腫瘤治療產品。

公司介紹

公司代碼GERN

公司名稱傑龍

上市日期1996/07/30

發行價格8.00

成立日期1990

CEOMs. Dawn Carter Bir

所屬市場納斯達克

員工數量229

年結日12-31

公司地址919 East Hillsdale Boulevard,Suite 250

城市Foster City

省份加利福尼亞州

國家美國

郵編94404

電話1-650-473-7700

網址http://www.geron.com

董事高管

姓名
職務
年薪

Dawn Carter Bir
Director, Interim President and Chief Executive Officer
34.31萬

Scott A. Samuels
Executive Vice President, Chief Legal Officer and Corporate Secretary
360.87萬

Michelle Robertson
Executive Vice President, Finance, Chief Financial Officer, Principal Accounting Officer and Treasurer
246.97萬

Melissa A. Kelly Behrs
Executive Vice President, Business Operations and Chief Alliance Officer
--

James Ziegler
Executive Vice President and Chief Commercial Officer
--

Dr. Andrew J. Grethlein,PhD
Executive Vice President and Chief Operating Officer
241.51萬

Shannon T. Odam
Senior Vice President and Chief People Officer
--

Dr. Faye Feller, M.D.
Executive Vice President and Chief Medical Officer
--

Edward E. Koval
Executive Vice President and Chief Business Officer
--

Dr. Joseph Emile Eid
Executive Vice President, Research and Development
--

Elizabeth G. O’Farrell
Chairman of the Board and Lead Independent Director
37.55萬

Dr. Gaurav Aggarwal, M.D.
Independent Director
29.08萬

Dr. Robert J. Spiegel, F.A.C.P.,M.D.
Independent Director
35.09萬

John F. McDonald
Independent Director
34.84萬

Dr. Susan M. Molineaux, PhD
Independent Director
34.59萬

Dr. V. Bryan Lawlis, PhD
Independent Director
36.09萬

GERN 傑龍

關於傑龍公司

公司介紹

董事高管

熱門市場機會